Picture of Spyre Therapeutics logo

SYRE — Spyre Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

U.S. RESEARCH ROUNDUP- American Airlines, Jabil, Lennar

June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including American Airlines, Jabil and Lennar, on Wednesday.

      HIGHLIGHTS

* American Airlines AAL.O: Bernstein cuts target price to $14 from $15
* Jabil Inc JBL.N: JP Morgan raises target price to $214 from $180
* Lennar Corp LEN.N: RBC cuts target price to $98 from $122
* United Airlines UAL.O: Bernstein cuts target price to $104 from $105
* Verve Therapeutics Inc VERV.O: Jefferies cuts to hold from buy
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Akamai Technologies Inc AKAM.O: Needham assumes coverage with hold rating
* Alcoa Corp AA.N: JP Morgan raises target price to $28 from $25
* American Airlines AAL.O: Bernstein cuts target price to $14 from $15
* American Public Education APEI.O: Northland Capital initiates coverage with outperform rating
* American Public Education APEI.O: Northland Capital initiates coverage with PT $36
* AT&T Inc T.N: UBS raises target price to $31 from $30
* Backblaze Inc BLZE.O: Needham assumes coverage with buy rating; PT $7 vs $8
* Biohaven Ltd BHVN.N: JP Morgan cuts target price to $55 from $68
* Campbell's Co CPB.O: TD Cowen cuts target price to $33 from $36
* Capital One Financial COF.N: Deutsche Bank raises target price to $215 from $212
* Cardinal Health Inc CAH.N: Deutsche Bank raises target price to $163 from $148
* Cava Group Inc CAVA.N: Stifel cuts target price to $125 from $175
* Charter Communications Inc CHTR.O: UBS raises target price to $425 from $400
* Cloudflare NET.N: Needham assumes coverage with buy rating; price target $200
* Constellation Brands Inc STZ.N: BofA Global Research cuts PT to $180 from $195
* Constellation Brands Inc STZ.N: Citigroup cuts target price to $170 from $190
* CrowdStrike CRWD.O: Needham assumes coverage with buy rating; price target $530
* Darden Restaurants Inc DRI.N: Morgan Stanley raises target price to $235 from $215
* Darden Restaurants Inc DRI.N: Truist Securities raises target price to $252 from $230
* Darden Restaurants Inc DRI.N: Morgan Stanley raises target price to $235 from $215
* Darden Restaurants Inc DRI.N: Oppenheimer raises target price to $250 from $230
* Datadog Inc DDOG.O: BofA Global Research raises price objective to $150 from $138
* Davita Inc DVA.N: Bernstein cuts target price to $150 from $184
* Delta Air Lines Inc DAL.N: Bernstein cuts target price to $60 from $61
* Eledon Pharmaceuticals Inc ELDN.O: H.C. Wainwright assumes coverage with buy rating
* Eledon Pharmaceuticals Inc ELDN.O: H.C. Wainwright assumes coverage with PT $9
* Enphase Energy Inc ENPH.O: RBC cuts target price to $28 from $50
* Equifax Inc EFX.N: Stifel raises target price to $295 from $277
* First Solar Inc FSLR.O: RBC cuts target price to $188 from $230
* Fiserv Inc FI.N: Mizuho cuts target price to $194 from $200
* Flutter Entertainment Plc FLUT.N: HSBC raises target price to $259 from $254
* Fortinet Inc FTNT.O: Needham assumes coverage with hold rating
* Frontview REIT Inc FVR.N: BofA Global Research cuts PT to $11 from $15
* Frontview REIT Inc FVR.N: BofA Global Research cuts to underperform from neutral
* Gap Inc GAP.N: TD Cowen cuts target price to $29 from $31
* Gartner Inc IT.N: UBS cuts target price to $500 from $525
* General Mills GIS.N: BofA Global Research cuts price objective to $63 from $68
* Genworth Financial Inc GNW.N: KBW raises target price to $9 from $8.50
* Genworth Financial Inc GNW.N: KBW raises to outperform from market perform
* Hii HII.N: TD Cowen raises target price to $250 from $225
* Honeywell International Inc HON.O: Barclays raises target price to $258 from $243
* Honeywell International Inc HON.O: Barclays raises target price to $258 from $243
* IBM IBM.N: BofA Global Research raises price objective to $320 from $290
* Immuneering Corp IMRX.O: Mizuho raises target price to $10 from $8
* Jabil Inc JBL.N: Barclays raises target price to $223 from $206
* Jabil Inc JBL.N: JP Morgan raises target price to $214 from $180
* Jabil Inc JBL.N: UBS raises target price to $208 from $157
* JP Morgan JPM.N: BofA Global Research raises price objective to $325 from $300
* Lamb Weston Holdings Inc LW.N: BofA Global Research cuts PT to $56 from $60
* Lennar Corp LEN.N: Barclays cuts target price to $95 from $110
* Lennar Corp LEN.N: BofA Global Research cuts price objective to $105 from $110
* Lennar Corp LEN.N: RBC cuts target price to $98 from $122
* Lennar Corp LEN.N: UBS cuts target price to $146 from $164
* Lifemd Inc LFMD.O: BTIG raises target price to $18 from $15
* Marvell Technology Inc MRVL.O: BofA Global Research ups PT to $90 from $80
* McCormick & Company Inc MKC.N: Citigroup cuts target price to $77 from $80
* Microchip Technology MCHP.O: Truist Securities raises target price to $64 from $52
* Morgan Stanley MS.N: Citigroup raises target price to $130 from $125
* National Vision Holdings Inc EYE.O: BofA Global Research ups PT to $26 from $22
* Ncino Inc NCNO.O: JP Morgan initiates coverage with neutral rating; price target $30
* Nike Inc NKE.N: Barclays cuts target price to $53 from $60
* Nike Inc NKE.N: Needham cuts target price to $66 from $75
* Okta Inc OKTA.O: Needham assumes coverage with buy rating; price target $125
* Onsemi ON.O: Mizuho raises target price to $60 from $52
* Palo Alto Networks PANW.O: Needham assumes coverage with buy rating; PT $230
* Paychex Inc PAYX.O: JP Morgan raises target price to $148 from $140
* Plains All American Pipeline PAA.O: Mizuho raises target price to $22 from $20
* Plains GP Holdings LP PAGP.O: Mizuho raises target price to $22 from $20
* Qualys Inc QLYS.O: Needham assumes coverage with hold rating
* Rapid7 Inc RPD.O: Needham assumes coverage with hold rating
* Rev Group Inc REVG.N: Morgan Stanley raises target price to $46 from $33
* Roblox Corporation RBLX.N: Oppenheimer raises target price to $125 from $80
* Roku Inc ROKU.O: Citigroup raises target price to $84 from $68
* Sandisk SNDK.O: BofA Global Research initiates coverage with buy rating; PT $61
* Sarepta Therapeutics Inc SRPT.O: Barclays cuts target price to $29 from $89
* Sarepta Therapeutics Inc SRPT.O: Mizuho cuts target price to $40 from $85
* Sarepta Therapeutics Inc SRPT.O: TD Cowen cuts target price to $24 from $62
* Sarepta Therapeutics Inc SRPT.O: TD Cowen cuts to hold from buy
* Sentinelone Inc S.N: Needham assumes coverage with buy rating; PT $22 vs $23
* Simply Good Foods Co SMPL.O: Citigroup cuts target price to $40 from $43
* Southwest Airlines Co LUV.N: Bernstein cuts target price to $30 from $31
* Spyre Therapeutics Inc SYRE.O: Jefferies raises target price to $47 from $43
* Sunrun Inc RUN.O: RBC cuts target price to $5 from $12
* Sunrun Inc RUN.O: RBC cuts to sector perform from outperform
* Tenable Holdings Inc TENB.O: Needham assumes coverage with buy rating; PT $35
* United Airlines UAL.O: Bernstein cuts target price to $104 from $105
* Varonis Systems Inc VRNS.O: Needham assumes coverage with buy rating; PT $60 vs $67
* Venture Global Inc VG.N: RBC raises target price to $20 from $14
* Verve Therapeutics Inc VERV.O: H.C. Wainwright cuts to neutral rating
* Verve Therapeutics Inc VERV.O: Jefferies cuts target price to $11 from $28
* Verve Therapeutics Inc VERV.O: Jefferies cuts to hold from buy
* Verve Therapeutics Inc VERV.O: JP Morgan cuts target price to $12 from $16
* Vince Holding Corp VNCE.N: Noble Capital raises to outperform from market perform
* Watts Water Technologies Inc WTS.N: Stifel raises target price to $275 from $260
* Western Digital WDC.O: Morgan Stanley raises target price to $78 from $70
* Zillow Group Inc ZG.O: BofA Global Research raises price objective to $72 from $70
* Zoetis Inc ZTS.N: Stifel cuts to hold from buy; cuts target price to $160 from $165
* Zscaler Inc ZS.O: Needham assumes coverage with buy rating; price target $350
(Compiled by Bengaluru Newsroom) ((Diaries@thomsonreuters.com))

Recent news on Spyre Therapeutics

See all news